The effects of an AMPA receptor antagonist on the neurotoxicity of tetracaine intrathecally administered in rabbits.
We have reported that large concentrations of intrathecal local anesthetics increase glutamate concentrations in the cerebrospinal fluid (CSF) and cause neuronal injury in rabbits. In the current study we determined whether an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor antagonist, YM872, administered intrathecally, reduces neuronal injury caused by tetracaine. We first examined the effects of intrathecal YM872 10, 30, 100, or 300 mug in rabbits (n = 3 in each). YM872 produced reversible motor and sensory block in a dose-dependent manner. Then, we evaluated modulatory effects of YM872 (300 mug) on tetracaine-induced glutamate release and neuronal injury. Pretreatment of YM872 did not attenuate 1% or 2% tetracaine-induced increases in cerebrospinal fluid glutamate concentrations (n = 3 in each). For evaluation of neuronal injury, rabbits were assigned to 4 groups (n = 6 in each) and intrathecally received 1% tetracaine and saline (1%T), 1% tetracaine and YM872 (1%TY), 2% tetracaine and saline (2%T), or 2% tetracaine and YM872 (2%TY). The volume of saline, YM872, and tetracaine was 0.3 mL. Saline or YM872 was administered 30 min before tetracaine administration. Neurological and histopathological assessments were performed 1 wk after the administration. Two and 1 animals respectively, showed motor and sensory dysfunction in 1%T, whereas 5 animals showed both motor and sensory dysfunction in 2%T. YM872 improved 2% tetracaine-induced motor dysfunction and neuronal damage (chromatolytic neurons, identified by round-shaped cytoplasm with loss of Nissl substance from the central part of the cell and eccentric nuclei). In 2%TY, 3 animals showed normal motor function and 3 showed mild dysfunction (ability to hop, but not normally), whereas 4 animals showed moderate dysfunction (inability to hop) in 2%T (P = 0.042). Only 2 animals showed one chromatolytic neuron in 2%TY, whereas 5 animals showed 4-16 chromatolytic neurons in 2%T (P = 0.020). These results suggest that AMPA receptor activation is involved, at least in part, in the tetracaine-induced neurotoxicity in the spinal cord.
Koizumi
Yumika
Y
Department of Anesthesiology-Resuscitology Yamaguchi University School of Medicine, Yamaguchi, Japan.
Matsumoto
Mishiya
M
Yamashita
Atsuo
A
Tsuruta
Shunsuke
S
Ohtake
Takanao
T
Sakabe
Takefumi
T
D000818:Animals; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology*; D007278:Injections, Spinal; D011817:Rabbits; D018091:Receptors, AMPA / Q000037:antagonists & inhibitors* / Q000502:physiology; D013116:Spinal Cord / Q000187:drug effects* / Q000473:pathology; D013748:Tetracaine / Q000008:administration & dosage* / Q000037:antagonists & inhibitors / Q000633:toxicity*
D018691:Excitatory Amino Acid Antagonists; D018091:Receptors, AMPA; D013748:Tetracaine